Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-marketing Safety Study of SIBP's Inactivated, Split-virion Influenza Vaccine Administered in Chinese Subjects Aged 3 Years and Older

NCT02133456 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention, China as lead sponsor.

NCT NCT02133456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02133456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-marketing Safety Study of SIBP's Inactivated, Split-virion Influenza Vaccine Administered in Chinese Subjects Aged 3 Years and Older
Lead sponsor
Centers for Disease Control and Prevention, China
Phase
Observational
Overall status
Completed
Start date
January 31, 2014
Completion date
April 30, 2014
Enrollment
166,240 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, vaccination adverse event